Jan 19 - 25, 2026
AI-Powered Bioinformatics: Single-Cell, Tools, and Drug Discovery
January 31, 2026
Can AI models predict drug sensitivity from single-cell images? How do foundation models transform single-cell genomics? Which new tools enable semantic search across gene expression databases? This week's AI-driven bioinformatics breakthroughs cover single-cell AI, tools, and protein engineering.
CytoVerse: Single-Cell AI Foundation Models
CytoVerse provides single-cell AI foundation models accessible directly in web browsers, enabling scalable and privacy-preserving analysis of single-cell datasets. This breakthrough democratizes access to cutting-edge AI for single-cell research, allowing researchers without computational resources to leverage foundation models.
AI Single-Cell Imaging for Drug Screening
Regularized single-cell imaging enables generalizable AI models for stain-free cell viability screening. This approach eliminates the need for toxic stains while maintaining prediction accuracy, accelerating drug discovery workflows.
Semantic Search for Gene Expression Datasets
Using semantic search powered by natural language processing to find publicly available gene expression datasets enables researchers to discover relevant data more efficiently. This AI-driven approach connects researchers with compatible datasets across repositories.
muPharma: AI-Driven Drug Sensitivity Prediction
An AI-driven pharmacotyping platform enables single-cell drug sensitivity prediction in leukemia without direct drug exposure. By quantifying pretreatment biomarkers, muPharma integrates microfluidic technology with machine learning to personalize treatment.
AI-Powered Aptamer Discovery
New AI methods for aptamer discovery enable identification of high-affinity nucleic acid binders for diagnostics and therapeutics. These machine learning approaches accelerate the development of biosensors and targeted therapies.